Increasing access to treatment may be one area of compromise between Democratic lawmakers and President Donald Trump.

More than 10,500 Harvard workers, represented by five unions, will negotiate new contracts with the University in 2025, ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

FINRA issued its 2025 Annual Regulatory Oversight Report, providing a detailed look into FINRA’s current regulatory oversight ...

President Donald Trump has repeatedly called for Canada to become the 51st US state, effectively erasing the 5,525-mile ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Street rubber that can handle a trackday or two The job of a sportbike tire is a tough one. Considering the performanc ...

Annual Regulatory Oversight Report provides member firms with key insights and observations from its regulatory operations programs. The report covers fixtures such as financial crimes prevention, ...

Pioneering license agreement with BrainTransporter signed with BMS worth up to USD 1.35 billion plus royalties Events during the fourth quarter 2024 The Australian Medicines Agency (TGA) decided not ...

"Wide discounts, underperformance and, in some cases, board inaction have provoked the ire of activist investor Saba Capital ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, ...